Effect of TXA on Reducing Bruising After Filler Injection
Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study
Sponsor: University of Wisconsin, Madison
Listed as NCT06665594, this PHASE2 trial focuses on Facial Filler Injections and Hyaluronic Acid and remains actively recruiting participants. Sponsored by University of Wisconsin, Madison, it has been updated 12 times since 2025, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE2
-
Jan 2026 — Feb 2026 [monthly]
Recruiting PHASE2
-
Dec 2025 — Jan 2026 [monthly]
Recruiting PHASE2
-
Nov 2025 — Dec 2025 [monthly]
Recruiting PHASE2
-
Oct 2025 — Nov 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 7 earlier versions
-
Sep 2025 — Oct 2025 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2025 — Aug 2025 [monthly]
Not Yet Recruiting PHASE2
-
May 2025 — Jul 2025 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2025 — May 2025 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .